Ensuring the Appropriate Use of Glucagon-Like Peptide-1 Receptor Agonists.

IF 2.9 4区医学

Journal of Clinical Pharmacology Pub Date : 2025-02-01 Epub Date: 2024-09-19 DOI:10.1002/jcph.6136

Kenneth Todd Moore, Aman Gupta, Jinshan Shen, Parag Kumar

引用次数: 0

查看原文本刊更多论文

确保适当使用胰高血糖素样肽-1 受体激动剂。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Pharmacology PHARMACOLOGY & PHARMACY-

自引率

3.40%

发文量

期刊介绍： The Journal of Clinical Pharmacology (JCP) is a Human Pharmacology journal designed to provide physicians, pharmacists, research scientists, regulatory scientists, drug developers and academic colleagues a forum to present research in all aspects of Clinical Pharmacology. This includes original research in pharmacokinetics, pharmacogenetics/pharmacogenomics, pharmacometrics, physiologic based pharmacokinetic modeling, drug interactions, therapeutic drug monitoring, regulatory sciences (including unique methods of data analysis), special population studies, drug development, pharmacovigilance, womens’ health, pediatric pharmacology, and pharmacodynamics. Additionally, JCP publishes review articles, commentaries and educational manuscripts. The Journal also serves as an instrument to disseminate Public Policy statements from the American College of Clinical Pharmacology.